Literature DB >> 10822072

Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines.

S Nomura1, A Imamura, M Okuno, Y Kamiyama, Y Fujimura, Y Ikeda, S Fukuhara.   

Abstract

We evaluated the plasma concentrations of cytokines and platelet-derived microparticles in patients with arteriosclerosis obliterans and studied the effect of cytokines on platelet-derived microparticle generation under high shear stress. Interleukin-6 levels peaked at 48 hours after vascular surgery, while thrombopoietin started to increase at 24 to 48 hours postoperatively and peaked on the seventh day. Platelet activation markers were increased in the arteriosclerosis obliterans patients preoperatively. Levels of P-selectin and CD63 both increased further, peaking at 6 to 24 hours postoperatively. Platelet-derived microparticle levels were also increased preoperatively. At 6 hours postoperatively, the plasma level of platelet-derived microparticles was significantly increased. Plasma platelet-derived microparticle level was lower at 12 hours but only returned to the preoperative value at 7 days after grafting. There was a difference in the platelet-derived microparticle level at 7 days between patients with or without antiplatelet therapy (cilostazol). The effect of cytokines on platelet activation under high shear stress was also studied. Interleukin-6 and thrombopoietin enhanced both P-selectin expression and platelet-derived microparticle generation under high shear stress. These results suggest that platelet-derived microparticles are released by platelet activation after vascular grafting when certain cytokines increase under high shear stress and that antiplatelet therapy may reduce platelet-derived microparticle levels postoperatively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10822072     DOI: 10.1016/s0049-3848(00)00186-9

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  18 in total

Review 1.  Function and clinical significance of platelet-derived microparticles.

Authors:  S Nomura
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

Review 2.  Microparticles and cardiovascular diseases.

Authors:  Christos Voukalis; Eduard Shantsila; Gregory Y H Lip
Journal:  Ann Med       Date:  2019-06-17       Impact factor: 4.709

3.  Aging- and activation-induced platelet microparticles suppress apoptosis in monocytic cells and differentially signal to proinflammatory mediator release.

Authors:  Elena M Vasina; Sandra Cauwenberghs; Mareike Staudt; Marion Ah Feijge; Christian Weber; Rory R Koenen; Johan Wm Heemskerk
Journal:  Am J Blood Res       Date:  2013-05-05

Review 4.  Multipotent role of platelets in inflammatory bowel diseases: a clinical approach.

Authors:  Evangelos Voudoukis; Konstantinos Karmiris; Ioannis E Koutroubakis
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

Review 5.  Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.

Authors:  Ying Wang; Li-ming Chen; Ming-lin Liu
Journal:  Acta Pharmacol Sin       Date:  2014-03-10       Impact factor: 6.150

Review 6.  Is hypertension a prothrombotic state?

Authors:  George I Varughese; Gregory Y H Lip
Journal:  Curr Hypertens Rep       Date:  2005-06       Impact factor: 5.369

7.  Quantifying the effects of shear stress and shear exposure duration regulation on flow induced platelet activation and aggregation.

Authors:  David A Rubenstein; Wei Yin
Journal:  J Thromb Thrombolysis       Date:  2010-07       Impact factor: 2.300

Review 8.  Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: a form of communication during injury, infection, and cell damage. It is never known how far a controversial finding will go! Dedicated to Ferruccio Ritossa.

Authors:  Antonio De Maio
Journal:  Cell Stress Chaperones       Date:  2010-10-21       Impact factor: 3.667

Review 9.  Bench-to-bedside review: circulating microparticles--a new player in sepsis?

Authors:  Ferhat Meziani; Xavier Delabranche; Pierre Asfar; Florence Toti
Journal:  Crit Care       Date:  2010-10-20       Impact factor: 9.097

Review 10.  Clinical significance of procoagulant microparticles.

Authors:  Shosaku Nomura; Michiomi Shimizu
Journal:  J Intensive Care       Date:  2015-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.